Article Text

Download PDFPDF
Change to Australasian College of Sport and Exercise Physicians—position statement: the place of mesenchymal stem/stromal cell therapies in sport and exercise medicine
  1. Hamish Osborne1,
  2. Adam Castricum2
  1. 1Department of Medicine, University of Otago, Otago Medical School, Dunedin, New Zealand
  2. 2Australasian College of Sport and Exercise Physicians, Melbourne, Victoria, Australia
  1. Correspondence to Dr Hamish Osborne, University of Otago, Department of Medicine, Otago Medical School, P.O. Box 56, Dunedin 9054, New Zealand; Hamish.osborne{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The Board of the Australasian College of Sport and Exercise Physicians has recently learnt concerns of the Australian Government, other medical colleges and our own fellowship regarding the safety of procedures involved with the provision of stem cell therapy to patients. These concerns are partially driven by reports recently published in the lay media, scientific literature and a coroner’s report.

A recent case report in the New England Journal of Medicine1 of a glioproliferative tumour in the spine after treatment with a mixture of mesenchymal, embryonic and fetal allogeneic stem cells for residual effects of a stroke warrants significant concern regarding the safety of unregulated innovative procedures.

Closer to home, a coroner’s recent report into the death of …

View Full Text


  • Twitter Follow Hamish Osborne at @Hamish_Osborne and Adam Castricum at @ACSP_SportsDocs

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Linked Articles